SGLT2 Inhibitors for Primary and Secondary Prevention of Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Cardiovascular Outcome Trials
Among women taking the 12mg dose, 93.2% achieved at least 10% body weight reduction
10.1371/journal.pone.0053096 166 TsengC
Yes Semaglutide and other GLP-1 medications are FDA-approved and have been used for years in managing diabetes and, more recently, weight loss
Poots 2 , Esther Oliva 3 , Tatyana Ionova 4 , Samantha Nier 5 1 University of Hertfordshire, Hatfield, UK, 2 Picker Institute Europe, Oxford, UK, 3 London North West University Healthcare NHS Trust, London, UK, 4 Saint Petersburg State University Hospital, St Petersburg, Russia, 5 Acute Leukaemia Advocates Network (ALAN), Bone, Switzerland Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :203.5 Aims Leukaemia is a blood cancer that impacts survival and patients quality of life (QoL)
The fat loss index, which measures the proportion of total weight lost that comes from fat, ranged from 62.0% to 69.3% across the effective doses